E. Gwyn Thomas

Uni Targeting Research AS is a holding company that provides the biopharmaceutical industry with tools and services for mammalian cell-line based development procedures and production processes. It offers upstream solutions to reduce complementary deoxyribonucleic acid and mammalian cell-line based timelines and increase protein production yields. Its technology enables both enhanced synthesis/secretion of naturally secreted proteins, and secretion of intracellular proteins. Its services include vector improvement, tailor-made vectors, and tool proteins. The company was founded by Ian Fraser Pryme, John E. Hesketh, Albert Tauler, and Beate Stern in 2001 and is headquartered in Bergen, Norway.

Balter Medical AS engages in the development and commercialization of biomedical technology. Its product assists healthcare professionals in diagnosing patients with Melanoma. The company was founded by Jakob Johan Stamnes and Knut Stamnes on December 13, 2000 and is headquartered in Bergen, Norway.

Lifearc provides research services. It specializes in intellectual property management, drug discovery, medical diagnostics and antibody engineering. The firm services include complete technology transfer service for scientists in MRC units and institutes, Awards to Inventors, Collaborative drug discovery and antibody engineering, Funding early stage research with commercial/translational potential and protecting new ideas. The company is headquartered in London, the United Kingdom.

The Royal Pharmaceutical Society of Great Britain provides expertise and support to its member pharmacists. The private company is based in Great Britain. Alex MacKinnon has been the CEO of the British company since 2010.

Oslo universitetssykehus HF operates local hospital, acute hospitals, and regional hospital for residents and has a number of national tasks. It carries out patient treatment, research, and trial treatments, gives advice and provides education. The company was founded on December 1, 2008 and is headquartered in Oslo, Norway.

Helse Bergen HF Haukeland Universitetssjukehus is a healthcare company based in Bergen, Norway. Haukeland universitetssjukehus has over 14,000 skilled employees who work every day to provide patients with high-quality specialist health services when they need them. The Norwegian company is ultimately controlled by the Government of Norway. The private company was founded in 2001, and the CEO is Eivind Hansen.

Part of Pfizer Inc., Pharmacia & Upjohn Co. LLC is a private company that manufactures and supplies pharmaceutical goods. The company is based in Bingham Farms, MI.

Pluvia AS operates as a research-based pharmaceutical company. The company is headquartered in Bergen, Norway.

Akershus Universitetssykehus HF operates as local and regional hospital. Its main tasks are patient treatment, research, teaching, and patient education. The firm offers somatic, mental health care, and drug treatment. The company was founded on December 5, 2001 and is headquartered in Lorenskog, Norway.

APIM Therapeutics AS develops and commercializes novel anti-cancer therapies. It offers a physiological intervention point allowing the potentiation of the action of clinical drugs across multiple cancer indications. The company focuses on the development and commercialization of novel anti-cancer therapies potentiating chemo-therapy induced responses in cancer cells. The company was founded by Marit Otterlei in 2009 and is headquartered in Trondheim, Norway.

Catalent Pharma Solutions Ltd. develops and markets drug delivery systems. The company is headquartered in Swindon, GB.

Part of Shionogi & Co., Ltd., Shionogi Ltd. is a British company that manufactures and distributes pharmaceutical products. The private company is based in London, UK.

IQVIA Ltd. provides professional services, information and partnering solutions. The firm serves its services to pharmaceutical, biotechnology, medical device and healthcare industries. It also provides contract research, sales, marketing, healthcare policy consulting and health information management services. The company was founded by Dennis Barry Gillings in 1995 and is headquartered in Reading, the United Kingdom.

Trialbee AB provides software solutions and services to the pharmaceutical industry. It operates as a software company which specializes in clinical trial planning and management solutions. The firm offers global pharmaceutical companies and web-based solution for patient recruitment to clinical trials. The company was founded by Carl Johan Tobias Folkesson and Per Jonas Billing in October 2010 and is headquartered in Malmo, Sweden.

Branding Science UK Ltd. provides market research services. The private company is based in London, UK.

Part of Bristol Myers Squibb Co., Bristol-Myers Squibb GmbH & Co. KGaA is a German company that manufactures biopharmaceutical medicines. The private company is based in Munich, Germany. The CEO of the company is Han Steutel.

Branding Science Group Ltd. is a British company that provides market research and consulting services for the pharmaceutical industry. The private company is based in London, UK. and has subsidiaries in United Kingdom. The company was founded in 2012.

DRI Capital, Inc. (DRI Capital) is a private equity firm, a subsidiary of Persis Holdings Ltd founded in 1992. The firm is headquartered in Toronto, Canada.

The University of Liverpool operates as a university. It offers post graduate research, foundation courses, continuing and professional development, online study, and doctoral college. The company was founded in 1881 and is headquartered in Liverpool, the United Kingdom.

Eli Lilly Norge AS engages in the provision of pharmaceutical products and services. Its commodities were developed for the treatment of diabetes, cardiovascular diseases, cancer, nervous system, osteoporosis, psoriasis, rheumatology, urology, and growth failure. The company was founded in 1976 and is headquartered in Oslo, Norway.

Gyros AB engages in the utilization of microfluidic technologies to miniaturize and automate immunoassays. Its Gyrolab xP miniaturizes, integrates, and automates analysis of samples in parallel. The firm's technology delivers immunoassay data through automated control of centrifugal and capillary forces to steer liquid flow in proprietary nanoliter-scale microfluidic structures.The company offers Gyrolab microlaboratory, in the form of a compact disk, can process samples at nanoliter scale, controlled by Gyrolab Workstation. Gyros was founded in 2000 and is headquartered in Uppsala, Sweden.

Part of PricewaterhouseCoopers International Ltd., PricewaterhouseCoopers (Denmark) is a private company based in Hellerup, Denmark.

MetaCure (USA), Inc. engages in the development and commercialization of invasive treatment for diabetes. The company was founded by Shlomo Ben-Haim in 2003 and is headquartered in Orangeburg, NY.

Cellectricon AB provides cell-based screening services to accelerate drug discovery. The firm develops and validates exciting central nervous system and peripheral pain assays using primary cells, accelerating the path from assay validation to compound screening. Its system is equipped with an imaging-based microplate reader to simultaneously record transient fluorescence and luminescence signals, providing real-time monitoring and readouts of cell culture response. The company was founded by Jan Owe Owesson Orwar, Daniel T. Chiu and Stig Anders Jakob Lindberg in 1999 and is headquartered in Molndal, Sweden.

Part of Biocoat, Inc., Chempilots A/S is a Danish company that specializes in developing and providing custom polymers using state-of-the-art technology. The private company is based in Farum, Denmark. The company offers a range of pre-specified products to signify their capabilities and give customers a starting point for selection. Chempilots specializes in poly(ortho esters) (poe), which belong to a class of degradable polymeric materials and were initially developed for drug delivery applications. Chempilots was acquired by Biocoat, Inc. on July 11, 2023.

Symphogen A/S provides antibody therapeutics for the treatment of cancers. It offers oncology products and creates selected antibody mixtures that address multiple oncology targets in a single drug product. The firm’s pipeline is fueled by its technology suite capable of identifying, selecting, manufacturing, and characterizing optimal antibody mixtures. The company was founded by Kirsten Aarup Drejer, Thomas Feldthus, Eigil Bjerl Nielsen, Anker Gunvald Lundemose, Kim Arthur Hueg, and John Soerensen Haurum in 2000 and is headquartered in Ballerup, Denmark.